435930-10MG Display Image

LIM Kinase Inhibitor I; LIMKi 3

Code: 435930-10MG D2-231

Biochem/physiol Actions

Reversible: yes

Secondary TargetAMPKA1, AMPKA2, DDR1, PAK3, DCAMKL2

Primary TargetLIMK1 and LIMK2

Target IC50: 7 and 8 nM...


read more

Your Price
£240.00 10MG
£288.00 inc. VAT

Biochem/physiol Actions

Reversible: yes

Secondary TargetAMPKA1, AMPKA2, DDR1, PAK3, DCAMKL2

Primary TargetLIMK1 and LIMK2

Target IC50: 7 and 8 nM against LIMK1 and LIMK2, respectively

Cell permeable: yes

General description

A cell-permeable pyrazolylthiazolo-isobutyramide compound that acts as a potent LIM kinase inhibitor (IC50 = 7 and 8 nM against LIMK1 and LIMK2, respectively) and effectively suppresses cellular cofilin phosphorylation (IC50 ~ 1 µM in A549 and MDA-MB-231 cultures) without affecting tubulin polymerization or inducing cytotoxicity (EC50 >10 µM in A549 proliferation and colony formation assays). Shown to effectively destabilize F-actin structure in MDA-MB-231 breast cancer cells (3 to 10 µM) with concomitant blockage of invadopedia-mediated ECM degradation (13% and 10% of control, respectively, by 3 and 10 µM inhibitor) and invasion (45% and 7% of control invasion rate, respectively, by 3 and 10 µM inhibitor). Although reported to exhibit affinity toward AMPKA1 and AMPKA2 in T7 phage-based competition binding studies, inhibitory activity of LIMKi 3 against AMPKA1/2 is not yet directly demonstrated.

A cell-permeable pyrazolylthiazolo-isobutyramide compound that acts as a potent LIM kinase inhibitor (IC50 = 7 and 8 nM against LIMK1 and LIMK2, respectively) and effectively suppresses cellular cofilin phosphorylation (IC50 ~ 1 µM in A549 and MDA-MB-231 cultures) without affecting tubulin polymerization or inducing cytotoxicity (EC50 >10 µM in A549 proliferation & colony formation assays). Shown to effectively destabilize F-actin structure in MDA-MB-231 breast cancer cells (3 to 10 µM) with concomitant blockage of invasion (by 93% at 10 µM).

Legal Information

CALBIOCHEM is a registered trademark of Merck KGaA, Darmstadt, Germany

Other Notes

Scott, R.W., et al. 2010. J. Cell. Biol.191, 169.r>Ross-Macdonald, P., et al. 2008. Mol. Cancer Ther.7, 3490.

Packaging

Packaged under inert gas

10 mg in Glass bottle

Reconstitution

Following reconstitution, aliquot and freeze (-20°C). Stock solutions are stable for up to 6 months at -20°C.

Warning

Toxicity: Standard Handling (A)

assay≥95% (HPLC)
colorbeige
formpowder
manufacturer/tradenameCalbiochem®
Quality Level100
shipped inambient
SMILES stringClC1=CC=CC(Cl)=C1N2N=C(C=C2C3=CN=C(NC(C(C)C)=O)S3)C(F)F
solubilityDMSO: 100 mg/mL
storage conditionprotect from light, OK to freeze
storage temp.2-8°C
Cas Number1338247-35-0
This product has met the following criteria: